Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide (Q74642726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

R P Pauly

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H U Demuth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F Rosche

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J Schmidt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

H A White

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C H McIntosh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R A Pederson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

385-389

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel [...]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Dipeptidyl Peptidase IV in the Immune System. Effects of Specific Enzyme Inhibitors on Activity of Dipeptidyl Peptidase IV and Proliferation of Human Lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Recent developments in inhibiting cysteine and serine proteases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Effect of jejunoileal bypass in the rat on the enteroinsular axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Glucagon-like peptide: a therapeutic glimmer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

Glucagon-like peptide 1 and its potential in the treatment of non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990090-2

10.1016/S0026-0495(99)90090-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10094118%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference